Boston Properties has acquired 153 and 211 Second Ave., two lab properties comprising 153,000 square feet in Waltham, Mas., a highly desirable location for leading and emerging companies in the life sciences and biotechnology sector.
The company acquired the two lab buildings from an affiliate of Montana Avenue Capital Partners for $100 million.
153 and 211 Second Ave. are 100 percent leased to a leading pharmaceutical company and are adjacent to Boston Properties’ 200 West St. building, a 272,000-square-foot property, a portion of which was recently converted to lab space, that is 100 percent leased to Translate Bio. The acquisition builds on Boston Properties’ 4.9 million square feet of lab and class A office properties in the Waltham/Lexington region of Massachusetts.
“Waltham continues to be a dominant urban edge location for life sciences organizations that want to attract and retain highly educated talent,” said Bryan Koop, vice president, Boston r
